These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15289286)

  • 1. The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism.
    Koizumi M; Sakoori K; Midorikawa N; Murphy NP
    Br J Pharmacol; 2004 Sep; 143(1):53-62. PubMed ID: 15289286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of the nociceptin receptor antagonist Compound B on the development of methamphetamine sensitization in mice: a behavioral and c-fos expression mapping study.
    Okabe C; Murphy NP
    Brain Res; 2004 Aug; 1017(1-2):1-12. PubMed ID: 15261093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
    J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice.
    Koizumi M; Midorikawa N; Takeshima H; Murphy NP
    J Neurochem; 2004 Apr; 89(1):257-63. PubMed ID: 15030410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS; Marti M; Morari M
    Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.
    Bregola G; Zucchini S; Rodi D; Binaschi A; D'Addario C; Landuzzi D; Reinscheid R; Candeletti S; Romualdi P; Simonato M
    J Neurosci; 2002 Nov; 22(22):10030-8. PubMed ID: 12427860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.
    Yamada S; Kusaka T; Urayama A; Kimura R; Watanabe Y
    Br J Pharmacol; 2003 Aug; 139(8):1462-8. PubMed ID: 12922933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.
    Rorick-Kehn LM; Ciccocioppo R; Wong CJ; Witkin JM; Martinez-Grau MA; Stopponi S; Adams BL; Katner JS; Perry KW; Toledo MA; Diaz N; Lafuente C; Jiménez A; Benito A; Pedregal C; Weiss F; Statnick MA
    Alcohol Clin Exp Res; 2016 May; 40(5):945-54. PubMed ID: 27084498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
    Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
    J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats.
    Di Giannuario A; Pieretti S; Catalani A; Loizzo A
    Neurosci Lett; 1999 Sep; 272(3):183-6. PubMed ID: 10505611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice.
    Murphy NP; Lam HA; Maidment NT
    J Neurochem; 2001 Nov; 79(3):626-35. PubMed ID: 11701766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
    Viaro R; Calcagno M; Marti M; Borrelli E; Morari M
    Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.
    Vazquez-DeRose J; Stauber G; Khroyan TV; Xie XS; Zaveri NT; Toll L
    Eur J Pharmacol; 2013 Jan; 699(1-3):200-6. PubMed ID: 23219985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
    Marti M; Trapella C; Morari M
    J Neurochem; 2008 Dec; 107(6):1683-96. PubMed ID: 19014386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of CompB on orphanin FQ-induced colonic contractions in rats.
    Tada H; Nakagawa K; Yamamura T; Takahashi T
    Eur J Pharmacol; 2002 Nov; 454(1):53-8. PubMed ID: 12409005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.